Phase II study assessing the efficacy and safety of lenvatinib for anaplastic thyroid cancer
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Jun 2016 New trial record